Back to Awarded Treatment Trials
Awarded Trial: 06T-812
Grant ID
06T-812
Illness
Bipolar Depression
Primary Drug/Intervention
Ceftriaxone
Primary Dosage
1 g/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Canceled
Investigator
Bhagwagar
Sample Size
30
Duration of Study Period for Each Subject
4 weeks
Outcome Measurements
Hamilton Depression Rating Scale, Montgomery Asberg Depression Rating Scale, and Clinical Global Impressions
Results
The plan was to randomize 30 bipolar patients to a trial of IV ceftrixone, thought to provide neuroprotection through glutamate clearance. Because of side effects and an infection, the trial was canceled after 8 patients had been randomized.
Publication
N/A
Link
N/A
PI Name
Zubin Bhagwagar
Degree
MD
Center
N/A
Institution
Yale University
Address
34 Park Street
City or Town
New Haven
State or Province
CT
Zip or Postal Code
6519
Country
USA
Email Address
zubin.bhagwagar@yale.edu